JP2023552846A5 - - Google Patents
Info
- Publication number
- JP2023552846A5 JP2023552846A5 JP2023535046A JP2023535046A JP2023552846A5 JP 2023552846 A5 JP2023552846 A5 JP 2023552846A5 JP 2023535046 A JP2023535046 A JP 2023535046A JP 2023535046 A JP2023535046 A JP 2023535046A JP 2023552846 A5 JP2023552846 A5 JP 2023552846A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- antibody
- antigen
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2020/085014 | 2020-12-08 | ||
| EP2020085014 | 2020-12-08 | ||
| EPPCT/EP2020/085747 | 2020-12-11 | ||
| EP2020085747 | 2020-12-11 | ||
| PCT/EP2021/084520 WO2022122704A1 (en) | 2020-12-08 | 2021-12-07 | Antibodies binding to f-protein of metapneumovirus and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023552846A JP2023552846A (ja) | 2023-12-19 |
| JP2023552846A5 true JP2023552846A5 (cg-RX-API-DMAC7.html) | 2024-11-22 |
Family
ID=78844890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023535046A Ceased JP2023552846A (ja) | 2020-12-08 | 2021-12-07 | メタニューモウイルスのf-タンパク質に結合する抗体およびその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240034772A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4259654A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023552846A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022122704A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004076677A2 (en) | 2003-02-26 | 2004-09-10 | Institute For Research In Biomedicine | Monoclonal antibody production by ebv transformation of b cells |
| US7700097B2 (en) | 2003-06-27 | 2010-04-20 | Biogen Idec Ma Inc. | Purification and preferential synthesis of binding molecules |
| JP4976376B2 (ja) * | 2005-04-08 | 2012-07-18 | メディミューン,エルエルシー | 哺乳動物メタニューモウイルスに対する抗体 |
| JP2010505876A (ja) * | 2006-10-04 | 2010-02-25 | ザ スクリプス リサーチ インスティテュート | ヒトメタニューモウイルスを中和するヒト抗体 |
| MX2009012343A (es) | 2007-05-14 | 2010-02-10 | Biogen Idec Inc | Regiones fc (sc fc) de cadena sencilla, polipeptidos de enlace que comprenden las mismas, y metodos relacionados con ello. |
| ES2525346T3 (es) | 2008-10-22 | 2014-12-22 | Institute For Research In Biomedicine | Métodos para producir anticuerpos a partir de células plasmáticas |
| US8326547B2 (en) | 2009-10-07 | 2012-12-04 | Nanjingjinsirui Science & Technology Biology Corp. | Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm |
| US10420834B2 (en) | 2014-12-24 | 2019-09-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Recombinant metapneumovirus F proteins and their use |
| US11312761B2 (en) * | 2016-10-21 | 2022-04-26 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| CN118359709A (zh) * | 2019-05-21 | 2024-07-19 | 佐治亚大学研究基金会有限公司 | 结合人类偏肺病毒融合蛋白的抗体及其用途 |
-
2021
- 2021-12-07 JP JP2023535046A patent/JP2023552846A/ja not_active Ceased
- 2021-12-07 US US18/256,419 patent/US20240034772A1/en active Pending
- 2021-12-07 EP EP21823890.5A patent/EP4259654A1/en not_active Withdrawn
- 2021-12-07 WO PCT/EP2021/084520 patent/WO2022122704A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Scheid et al. | B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV | |
| JP7328479B2 (ja) | 重症熱性血小板減少症候群ウイルスの外膜糖タンパク質に結合する抗体及びその用途 | |
| JP7209464B2 (ja) | ヒトインターロイキン-2に対する免疫刺激性モノクローナル抗体 | |
| US20200347130A1 (en) | CD96 Antibody, Antigen-Binding Fragment and Pharmaceutical use Thereof | |
| JP6421371B2 (ja) | トランスポーターに対する抗体およびその用途 | |
| JP2012518425A5 (cg-RX-API-DMAC7.html) | ||
| JP2005528914A5 (cg-RX-API-DMAC7.html) | ||
| AU2015322141A1 (en) | High affinity and aggregatively stable antibodies on the basis of variable domains Vl and a derivative VHH | |
| JP2020515277A5 (cg-RX-API-DMAC7.html) | ||
| JP7304288B2 (ja) | ジストログリカンおよびラミニン2に対する特異性を有する多特異性結合性分子 | |
| JP2017507131A5 (cg-RX-API-DMAC7.html) | ||
| JP2025507595A5 (cg-RX-API-DMAC7.html) | ||
| WO2021212785A1 (zh) | 一种全人源单克隆抗体及其应用 | |
| JPWO2022224997A5 (cg-RX-API-DMAC7.html) | ||
| CN114591434A (zh) | 抗Siglec15抗体及其制备方法和用途 | |
| JP2022528387A (ja) | アビド結合多重特異性抗体を作製する方法 | |
| JP2021515597A5 (cg-RX-API-DMAC7.html) | ||
| JP2024535124A5 (cg-RX-API-DMAC7.html) | ||
| KR20240031229A (ko) | 알파-시누클레인병증 치료용 항체 | |
| WO2021238854A1 (zh) | 抗SARS-CoV-2刺突蛋白的单克隆抗体及其制备方法和用途 | |
| TWI867354B (zh) | 新穎Nav1.7單株抗體 | |
| WO2020205504A1 (en) | Common light chains and methods of use | |
| CN115337396A (zh) | 一种全人源单克隆抗体组合及其应用 | |
| KR102845060B1 (ko) | 니파바이러스 및 헨드라바이러스에 특이적인 단클론항체 및 이의 용도 | |
| CN115433273B (zh) | 具有中和活性的抗新冠病毒兔重组单克隆抗体及应用 |